BioCiTi Afrobodies antibodies discovery
Amid the ongoing efforts to find a lasting solution to the COVID-19 pandemic, scientists from the Africa Health Research Institute (AHRI) in Durban, led by Dr Alex Sigal, have successfully tested antibodies developed by Cape Town biotech company, Afrobodies, against the SARS-CoV-2 501Y.V2 variant.
Afrobodies is based at the BioCiTi Lab and incubator at the Woodstock Bandwidth Barn (part of the Cape Innovation & Technology Initiative “CiTi”), where multiple biotech companies test their innovative solutions.
Afrobodies Chief Scientific Officer, Dr Peter Durcan, said the company felt privileged that their antibodies were among the first in the world to undergo laboratory testing against the so-called ‘SA variant'.